Active Stocks
Thu Mar 28 2024 15:59:33
  1. Tata Steel share price
  2. 155.90 2.00%
  1. ICICI Bank share price
  2. 1,095.75 1.08%
  1. HDFC Bank share price
  2. 1,448.20 0.52%
  1. ITC share price
  2. 428.55 0.13%
  1. Power Grid Corporation Of India share price
  2. 277.05 2.21%
Business News/ Companies / Ranbaxy signs new R&D pact with Glaxo
BackBack

Ranbaxy signs new R&D pact with Glaxo

Ranbaxy signs new R&D pact with Glaxo

Premium

By Agencies

Ranbaxy Laboratories Ltd., India’s biggest drugmaker, signed a new research and development agreement with GlaxoSmithKline Plc, Europe’s largest drugmaker.

Under the agreement, Ranbaxy could get more than $100 million in “milestone payments" for a product that it develops and that is sold by Glaxo, Ranbaxy, based in Gurgaon, India, said in a mailed statement today.

The new “multiyear" agreement expands the terms of the alliance formed between Ranbaxy and Glaxo in 2003 to provide the Indian company wider drug-development responsibilities, Ranbaxy said.

Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!

Catch all the Corporate news and Updates on Live Mint. Download The Mint News App to get Daily Market Updates & Live Business News.
More Less
Published: 07 Feb 2007, 04:18 PM IST
Next Story footLogo
Recommended For You
Switch to the Mint app for fast and personalized news - Get App

Chat with MintGenie